Jessica Tassan
Stock Analyst at Piper Sandler
(1.15)
# 3,772
Out of 5,072 analysts
78
Total ratings
31.82%
Success rate
-11.06%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jessica Tassan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Upgrades: Overweight | $13 → $25 | $17.97 | +39.12% | 7 | Nov 26, 2025 | |
| HNGE Hinge Health | Reiterates: Overweight | $70 → $71 | $48.91 | +45.16% | 2 | Nov 5, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $423 → $417 | $329.77 | +26.45% | 9 | Oct 29, 2025 | |
| PHR Phreesia | Maintains: Overweight | $33 → $34 | $20.49 | +65.93% | 6 | Sep 5, 2025 | |
| EVH Evolent Health | Maintains: Overweight | $16 → $18 | $4.20 | +328.57% | 4 | Aug 28, 2025 | |
| HCAT Health Catalyst | Downgrades: Neutral | $8 → $4 | $2.99 | +33.78% | 12 | Aug 27, 2025 | |
| CTEV Claritev | Maintains: Overweight | $44 → $86 | $54.07 | +59.05% | 3 | Aug 15, 2025 | |
| DOCS Doximity | Maintains: Overweight | $65 → $69 | $51.44 | +34.14% | 4 | Aug 11, 2025 | |
| HUM Humana | Maintains: Neutral | $288 → $272 | $245.77 | +10.67% | 4 | Jul 31, 2025 | |
| AMWL American Well | Reiterates: Neutral | $10 → $8 | $4.23 | +89.13% | 3 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $348 → $374 | $277.28 | +34.88% | 4 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $72 → $74 | $80.36 | -7.91% | 5 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $19.22 | +9.26% | 5 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $12 | $7.59 | +58.10% | 6 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $66 → $70 | $36.50 | +91.81% | 4 | Aug 2, 2023 |
Oscar Health
Nov 26, 2025
Upgrades: Overweight
Price Target: $13 → $25
Current: $17.97
Upside: +39.12%
Hinge Health
Nov 5, 2025
Reiterates: Overweight
Price Target: $70 → $71
Current: $48.91
Upside: +45.16%
UnitedHealth Group
Oct 29, 2025
Maintains: Overweight
Price Target: $423 → $417
Current: $329.77
Upside: +26.45%
Phreesia
Sep 5, 2025
Maintains: Overweight
Price Target: $33 → $34
Current: $20.49
Upside: +65.93%
Evolent Health
Aug 28, 2025
Maintains: Overweight
Price Target: $16 → $18
Current: $4.20
Upside: +328.57%
Health Catalyst
Aug 27, 2025
Downgrades: Neutral
Price Target: $8 → $4
Current: $2.99
Upside: +33.78%
Claritev
Aug 15, 2025
Maintains: Overweight
Price Target: $44 → $86
Current: $54.07
Upside: +59.05%
Doximity
Aug 11, 2025
Maintains: Overweight
Price Target: $65 → $69
Current: $51.44
Upside: +34.14%
Humana
Jul 31, 2025
Maintains: Neutral
Price Target: $288 → $272
Current: $245.77
Upside: +10.67%
American Well
May 23, 2025
Reiterates: Neutral
Price Target: $10 → $8
Current: $4.23
Upside: +89.13%
May 5, 2025
Maintains: Overweight
Price Target: $348 → $374
Current: $277.28
Upside: +34.88%
Mar 21, 2025
Maintains: Overweight
Price Target: $72 → $74
Current: $80.36
Upside: -7.91%
Mar 4, 2025
Maintains: Overweight
Price Target: $14 → $21
Current: $19.22
Upside: +9.26%
Feb 27, 2025
Maintains: Overweight
Price Target: $13 → $12
Current: $7.59
Upside: +58.10%
Aug 2, 2023
Downgrades: Neutral
Price Target: $66 → $70
Current: $36.50
Upside: +91.81%